LifeMD (LFMD) Competitors $4.70 -0.03 (-0.63%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LFMD vs. PNTG, AVAH, CSTL, AUNA, FLGT, SBC, TALK, DCGO, INNV, and CELCShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Auna (AUNA), Fulgent Genetics (FLGT), SBC Medical Group (SBC), Talkspace (TALK), DocGo (DCGO), InnovAge (INNV), and Celcuity (CELC). These companies are all part of the "healthcare" industry. LifeMD vs. The Pennant Group Aveanna Healthcare Castle Biosciences Auna Fulgent Genetics SBC Medical Group Talkspace DocGo InnovAge Celcuity The Pennant Group (NASDAQ:PNTG) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Which has stronger earnings and valuation, PNTG or LFMD? The Pennant Group has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Pennant Group$652.30M1.18$13.38M$0.7032.03LifeMD$193.06M1.03-$20.60M-$0.64-7.20 Do analysts rate PNTG or LFMD? The Pennant Group currently has a consensus price target of $36.00, indicating a potential upside of 60.56%. LifeMD has a consensus price target of $11.14, indicating a potential upside of 141.87%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than The Pennant Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60LifeMD 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Does the media prefer PNTG or LFMD? In the previous week, The Pennant Group had 13 more articles in the media than LifeMD. MarketBeat recorded 15 mentions for The Pennant Group and 2 mentions for LifeMD. LifeMD's average media sentiment score of 0.38 beat The Pennant Group's score of 0.07 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 2 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is PNTG or LFMD more profitable? The Pennant Group has a net margin of 3.24% compared to LifeMD's net margin of -12.06%. The Pennant Group's return on equity of 13.47% beat LifeMD's return on equity.Company Net Margins Return on Equity Return on Assets The Pennant Group3.24% 13.47% 3.81% LifeMD -12.06%N/A -36.34% Do insiders and institutionals hold more shares of PNTG or LFMD? 85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 5.8% of The Pennant Group shares are held by insiders. Comparatively, 16.0% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, PNTG or LFMD? The Pennant Group has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Does the MarketBeat Community prefer PNTG or LFMD? The Pennant Group received 4 more outperform votes than LifeMD when rated by MarketBeat users. However, 75.00% of users gave LifeMD an outperform vote while only 45.98% of users gave The Pennant Group an outperform vote. CompanyUnderperformOutperformThe Pennant GroupOutperform Votes4045.98% Underperform Votes4754.02% LifeMDOutperform Votes3675.00% Underperform Votes1225.00% SummaryThe Pennant Group beats LifeMD on 12 of the 18 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$201.14M$1.30B$5.81B$8.30BDividend YieldN/AN/A4.76%3.97%P/E Ratio-7.2617.3324.7818.99Price / Sales1.031.32372.02107.51Price / CashN/A36.0138.0534.62Price / Book30.718.537.204.20Net Income-$20.60M-$52.07M$3.18B$246.82M7 Day Performance-7.30%-6.79%-4.01%-4.63%1 Month Performance-27.10%-12.73%-7.80%-7.79%1 Year Performance-38.90%-8.37%11.13%2.41% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD2.0418 of 5 stars$4.70-0.6%$11.14+137.1%-40.9%$203.57M$193.06M-7.34230PNTGThe Pennant Group3.7435 of 5 stars$25.15+0.4%$36.00+43.1%+23.2%$863.90M$544.89M36.995,791Positive NewsAVAHAveanna Healthcare0.8956 of 5 stars$4.14-2.1%$4.51+9.0%+68.6%$799.97M$1.90B-12.1833,500Gap DownCSTLCastle Biosciences1.8691 of 5 stars$25.36-1.5%$40.29+58.9%+6.7%$710.33M$219.79M126.81540Analyst RevisionGap DownAUNAAuna3.8729 of 5 stars$8.06-0.6%$13.53+67.8%N/A$595.80M$1.04B0.0014,958Upcoming EarningsShort Interest ↓News CoverageFLGTFulgent Genetics3.7747 of 5 stars$16.75+1.8%$22.00+31.3%-34.3%$512.33M$277.76M-3.031,184Short Interest ↑SBCSBC Medical GroupN/A$4.70+3.1%N/AN/A$484.19MN/A0.00N/ANews CoverageTALKTalkspace4.4022 of 5 stars$2.85-5.3%$4.38+53.5%-7.0%$481.42M$187.59M285.29500Insider TradePositive NewsDCGODocGo2.4958 of 5 stars$4.44-7.3%$6.10+37.4%-27.6%$453.11M$694.97M15.864,164Analyst RevisionINNVInnovAge1.3028 of 5 stars$3.32flat$5.00+50.6%-33.5%$449.00M$763.85M-17.472,350Short Interest ↑Gap UpCELCCelcuity2.339 of 5 stars$11.18-15.0%$30.17+169.8%-48.9%$415.11MN/A-4.2840Positive News Related Companies and Tools Related Companies The Pennant Group Competitors Aveanna Healthcare Competitors Castle Biosciences Competitors Auna Competitors Fulgent Genetics Competitors SBC Medical Group Competitors Talkspace Competitors DocGo Competitors InnovAge Competitors Celcuity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LFMD) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.